ATE503748T1 - Anti-krebs- und antimikrobielle oxazolidinone und analoga - Google Patents

Anti-krebs- und antimikrobielle oxazolidinone und analoga

Info

Publication number
ATE503748T1
ATE503748T1 AT06735789T AT06735789T ATE503748T1 AT E503748 T1 ATE503748 T1 AT E503748T1 AT 06735789 T AT06735789 T AT 06735789T AT 06735789 T AT06735789 T AT 06735789T AT E503748 T1 ATE503748 T1 AT E503748T1
Authority
AT
Austria
Prior art keywords
cancer
oxazolidinones
analogues
antimicrobial
analogs
Prior art date
Application number
AT06735789T
Other languages
English (en)
Inventor
Venkata Macherla
Benjamin Nicholson
Kin Lam
Original Assignee
Nereus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nereus Pharmaceuticals Inc filed Critical Nereus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE503748T1 publication Critical patent/ATE503748T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/40—One oxygen atom attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
    • C07C257/06—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms, or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06735789T 2005-02-22 2006-02-22 Anti-krebs- und antimikrobielle oxazolidinone und analoga ATE503748T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65560505P 2005-02-22 2005-02-22
PCT/US2006/006278 WO2006091669A1 (en) 2005-02-22 2006-02-22 Anti-cancer and anti-microbial oxazolidinones and analogues

Publications (1)

Publication Number Publication Date
ATE503748T1 true ATE503748T1 (de) 2011-04-15

Family

ID=36580024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06735789T ATE503748T1 (de) 2005-02-22 2006-02-22 Anti-krebs- und antimikrobielle oxazolidinone und analoga

Country Status (14)

Country Link
US (3) US7378530B2 (de)
EP (1) EP1856066B1 (de)
JP (1) JP2008531573A (de)
KR (1) KR20070106578A (de)
CN (1) CN101160294A (de)
AT (1) ATE503748T1 (de)
AU (1) AU2006216708A1 (de)
BR (1) BRPI0607974A2 (de)
CA (1) CA2597667A1 (de)
DE (1) DE602006020992D1 (de)
IL (1) IL185266A0 (de)
MX (1) MX2007009990A (de)
WO (1) WO2006091669A1 (de)
ZA (1) ZA200707855B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378530B2 (en) * 2005-02-22 2008-05-27 Nereus Pharmaceuticals, Inc. Anti-cancer and anti-microbial 5-membered heterocyclic compounds
US20110118274A1 (en) * 2007-08-23 2011-05-19 Cornell Research Foundation, Inc. Proteasome inhibitors and their use in treating pathogen infection and cancer
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EA026161B1 (ru) * 2012-10-29 2017-03-31 Ф. Хоффманн-Ля Рош Аг Производные 3,4-дизамещенного оксазолидинона и их применение в качестве ингибиторов кальций-активируемых калиевых каналов
CN107709317B (zh) * 2015-07-03 2021-05-11 拜耳作物科学股份公司 具有除草作用的n-(1,3,4-噁二唑-2-基)芳基甲酰胺衍生物
US10548318B2 (en) * 2015-07-03 2020-02-04 Bayer Cropscience Aktiengesellschaft N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide derivatives with herbicidal action
CA3034677A1 (en) 2016-08-22 2018-03-01 North Carolina State University 5-benzylidene-4-oxazolidinones
US10844025B2 (en) 2016-08-22 2020-11-24 North Carolina State University 4-oxazolidinone antimicrobial agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2915527A (en) 1959-12-01 Oxazolidone compounds and means for
US2971958A (en) 1959-03-17 1961-02-14 Union Carbide Corp Cyanoethylated oxalactams
US3129222A (en) 1960-12-01 1964-04-14 Merck & Co Inc 2, 2, 5-trisubstituted-4-oxazolidinone compounds
US3182063A (en) 1961-03-06 1965-05-04 Warner Lambert Pharmaceutical Substituted 4-thiazolidinones and process therefor
DE1917615U (de) 1963-02-15 1965-06-10 Kloeckner Humboldt Deutz Ag Rotationskolbenmaschine.
DE1916715A1 (de) 1969-04-01 1970-10-08 Goedecke Ag Verfahren zur Herstellung von Oxazolidon-(4)-Derivaten
US4049816A (en) 1975-03-24 1977-09-20 Beecham Group Limited Antiviral 2-amino-5-[1-(indol-3-yl)alkyl]-2-thiazolin-4-ones
US4769232A (en) 1984-03-22 1988-09-06 Pfizer Inc. Parenteral formulations of indolmycin
US4584385A (en) 1984-03-22 1986-04-22 Pfizer Inc. Antibacterial 2-amino-oxazolinones and process therefor
US4650512A (en) 1984-09-27 1987-03-17 Stauffer Chemical Company Oxazolidone herbicides and methods of use
US4629794A (en) 1985-02-04 1986-12-16 Pfizer Inc. Antibacterial 2-amino-oxazolinones and process therefor
US5677463A (en) 1996-11-20 1997-10-14 Abbott Laboratories Process for the preparation of 2-imino-5-phenyl-4 oxazolidinone and its intermediates
AU4929899A (en) 1998-07-30 2000-02-21 Takeda Chemical Industries Ltd. Process for producing indolemycin
US7378530B2 (en) * 2005-02-22 2008-05-27 Nereus Pharmaceuticals, Inc. Anti-cancer and anti-microbial 5-membered heterocyclic compounds

Also Published As

Publication number Publication date
ZA200707855B (en) 2008-09-25
US7378530B2 (en) 2008-05-27
EP1856066B1 (de) 2011-03-30
EP1856066A1 (de) 2007-11-21
BRPI0607974A2 (pt) 2010-08-17
JP2008531573A (ja) 2008-08-14
CN101160294A (zh) 2008-04-09
IL185266A0 (en) 2008-02-09
CA2597667A1 (en) 2006-08-31
AU2006216708A1 (en) 2006-08-31
MX2007009990A (es) 2007-09-26
US20060205799A1 (en) 2006-09-14
US7879892B2 (en) 2011-02-01
KR20070106578A (ko) 2007-11-01
US20080221182A1 (en) 2008-09-11
WO2006091669A1 (en) 2006-08-31
US20080221183A1 (en) 2008-09-11
DE602006020992D1 (de) 2011-05-12

Similar Documents

Publication Publication Date Title
ZA200707855B (en) Anti-cancer and antimicrobial oxazolidinones and analogues
JOP20200130A1 (ar) مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية
GEP20156309B (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CO5570678A2 (es) N-alquilo-4-metileneamino-3-hidroxilo-2-piridonas como anti- microbianos
MX351589B (es) Antibioticos de oxazolidinona.
BRPI0717266A2 (pt) Derivados de oxindol
WO2007023507A3 (en) Oxazolidinones bearing antimicrobial activity composition and methods of preparation
CU23423B7 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea
ATE530561T1 (de) 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
BRPI0414694A (pt) pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas
MX2010008921A (es) Derivados de oxazolidinona.
EA201070169A1 (ru) 2,3-дигидробензо[1,4]диоксин-2-илметиловые производные в качестве альфа2с антагонистов для применения в лечении заболеваний перифирической центральной нервной системы
SV2008002958A (es) Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania referencia cruzada ref. prd2592sv
NO20081005L (no) 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
PE20090160A1 (es) COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
MX391911B (es) Compuesto antimicrobiano ((2r,3s,5r)-5-(4-amino-2-oxopirimidin-1(2h)- il)-3-((butoxióxidofosfor-il)oxi) tetrahidrofuran-2-il)metil butil fosfato, y el uso del mismo en infecciones.
BR112013014189A8 (pt) composição farmacêutica, uso de um agente de potencialização e uso de uma composição
RU2011153353A (ru) Кетолидные соединения, обладающие противомикробной активностью
CY1115690T1 (el) Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων
EA200701113A1 (ru) Макролиды
UA117922C2 (uk) Насичені азотовмісні та n-ациловані гетероцикли, що посилюють дію активного антибіотика проти мікобактерій
ATE516022T1 (de) Antimikrobielle zusammensetzungen und anwendungsverfahren dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties